Opinion
Motion No. 2023-00455 Index No. 157128/21Case No. 2022-03219
03-16-2023
In the Matter of the Application of Allergan Finance, LLC, Petitioner, v. New York State Department of Financial Services and Linda A. Lacewell, in her capacity as Superintendent of the New York State Department of Financial Services, Respondents-Respondents. Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc., Teva Pharmaceuticals USA, Inc., Cephalon, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., Actavis LLC, and Actavis Elizabeth LLC, Petitioners-Appellants, For a Judgment Pursuant to Article 78 of the Civil Practice Law and Rules,
Unpublished Opinion
MOTION DECISION
Present - Hon. Dianne T. Renwick, Justice Presiding, David Friedman Peter H. Moulton Manuel J. Mendez Bahaati E. Pitt-Burke, Justices.
Petitioners-appellants Teva Pharmaceuticals USA, Inc., Cephalon, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., Actavis LLC, and Actavis Elizabeth LLC, having moved for an extension of time to perfect the appeal taken from an order of the Supreme Court, New York County, entered on or about June 30, 2022,
Now, upon reading and filing the papers with respect to the motion, and due deliberation having been had thereon, It is ordered that the motion is granted and the time to perfect the appeal extended to the September 2023 Term of this Court.